无毒,多领域的肉毒神经毒素-LCHCN作为对肉毒主义的疫苗
A Przedpelski1, W H Tepp2, S Gupta2
1Medical College of Wisconsin, 8701 Watertown Plank Rd., Microbiology and Immunology, Milwaukee, WI 53226, United States of America.
Vaccine
|September 25, 2025
概括
开发安全有效的肉毒神经毒素 (BoNT) 疫苗至关重要. 这项研究通过使关键功能域失活,设计了新的BoNT疫苗,证明了对BoNT/A1和BoNT/B1的强效保护,在小鼠中没有毒性.
科学领域:
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 肉毒神经毒素 (BoNTs) 导致肉毒症,目前没有人类疫苗.
- 现有的BoNT候选疫苗往往保持残留毒性.
- BoNT结构包括一个催化轻链 (LC) 和一个重链 (HC),具有转位 (HCN) 和结合 (HCC) 域.
研究的目的:
- 开发一种安全且有效的针对肉毒神经毒素 (BoNTs) 的疫苗.
- 研究多域无活化作为一种降低BoNT毒性的策略,同时保持免疫性.
- 在小鼠模型中评估工程BoNT候选疫苗的保护疗效.
主要方法:
- 设计了多域BoNT/A1和BoNT/B1构造 (LCHCN) 用六点替换 (6M) 来禁用关键的功能站点.
- 在小鼠中对工程结构的评估毒性.
- 接种了6MLCHCN/A1或6MLCHCN/B1的免疫小鼠,并用BoNT/A1或BoNT/B1.1的致命剂量进行了挑战.
- 设计并测试了其他结构 (4MBoNT/B1,7MBoNT/B1).
主要成果:
- 工程6MLCHCN/A1和6MLCHCN/B1构造在200μg时在小鼠中没有可检测的毒性,与全长BoNT相比,毒性显著降低.
- 用6MLCHCN/A1或6MLCHCN/B1进行免疫接种引起了强烈的IgG反应.
- 接种疫苗的小鼠受到高剂量BoNT/A1或BoNT/B1挑战的保护.
- 其他构造 (4MBoNT/B1,7MBoNT/B1) 也诱导了保护性IgG反应.
结论:
- 通过有针对性的点置换来进行多域无活化是创建安全有效的BoNT疫苗的可行策略.
- 这种方法为开发针对各种BoNT血清型和相关蛋白质毒素的疫苗提供了一个强大的平台.
- 开发的候选疫苗显示出对人类和动物对肉毒的应用有前途.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Cross-reactivity
32.8K
Overview
32.8K
Skeletal Muscle Relaxants: Therapeutic Uses
913
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
913
Local Anesthetics: Clinical Application as Spinal Anesthesia
1.3K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.3K
Types of Toxins
3.2K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.2K
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972


